Global Drug Designing Tools Market

Drug Designing Tools Comprehensive Study by Type (Ligand-based drug design, Second, structure-based drug design.), Application (Chemical Screening, Molecular Modelling, Target Prediction, Binding Site Prediction, Docking), Solution Type (Multi Databases, Virtual Screening Tools, Structure Designing/ Building Tools, Predictive Analytics, Model Building Tools, Others) Players and Region - Global Market Outlook to 2028

Drug Designing Tools Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Drug designing tools are computer modeling techniques provide insights into experimental findings. These tools use computational chemistry to enhance, or study drugs and related biologically active molecules. Drug designing are done in two ways structure-based drug design and ligand-based drug design. All pharmaceutical and biotechnology companies use computational design tools. At their lowest level the contributions signify the replacement of crude mechanical models by displays of structure which are a much more accurate reflection of molecular reality capable of demonstrating motion and solvent effects.This growth is primarily driven by Growing Need for Cost- And Time-Effective Drug Designing Tools.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Application Software sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Schrödinger LLC (United States), Biovia Corporation (United States), Albany Molecular Research Inc. (United States), BioSolveIT GmbH (Germany), Agilent Technologies (United States), ChemAxon (Hungary) and Novo Informatics Pvt. Ltd. (India), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In August 2020,Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs. The technology is expected to be capable of enumerating, screening, and scoring billions of synthetically feasible, virtual compounds supporting the identification and optimization of potential new therapeutic candidates.
In Dec. 2023,Merck, a leading science and technology company, today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through SynthiaTM retrosynthesis software application programing interface (API) integrationThe companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies.

Influencing Trend:
Growing Need for Cost and Time Effective Tools and Rising Adoption of Intelligent Enterprise Technologies for Drug Designing

Market Growth Drivers:
Growing Need for Cost- And Time-Effective Drug Designing Tools

Challenges:
Design of Novel Drug is Difficult

Restraints:
High Costs of R&D and Human Clinical Tests

Opportunities:
Adoption of Advanced Technologies in Drug Designing and Increased Investments Made in Research and Innovation

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Drug Designing Tools Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Drug Designing Tools Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Drug Designing Tools players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Drug Designing Tools Study Sheds Light on
— The Drug Designing Tools Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Drug Designing Tools industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Drug Designing Tools industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • ligand-based drug design
  • second, structure-based drug design.
By Application
  • Chemical Screening
  • Molecular Modelling
  • Target Prediction
  • Binding Site Prediction
  • Docking
By Solution Type
  • Multi Databases
  • Virtual Screening Tools
  • Structure Designing/ Building Tools
  • Predictive Analytics
  • Model Building Tools
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Need for Cost- And Time-Effective Drug Designing Tools
    • 3.3. Market Challenges
      • 3.3.1. Design of Novel Drug is Difficult
    • 3.4. Market Trends
      • 3.4.1. Growing Need for Cost and Time Effective Tools
      • 3.4.2. Rising Adoption of Intelligent Enterprise Technologies for Drug Designing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Designing Tools, by Type, Application, Solution Type and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Drug Designing Tools (Value)
      • 5.2.1. Global Drug Designing Tools by: Type (Value)
        • 5.2.1.1. Ligand-based drug design
        • 5.2.1.2. Second, structure-based drug design.
      • 5.2.2. Global Drug Designing Tools by: Application (Value)
        • 5.2.2.1. Chemical Screening
        • 5.2.2.2. Molecular Modelling
        • 5.2.2.3. Target Prediction
        • 5.2.2.4. Binding Site Prediction
        • 5.2.2.5. Docking
      • 5.2.3. Global Drug Designing Tools by: Solution Type (Value)
        • 5.2.3.1. Multi Databases
        • 5.2.3.2. Virtual Screening Tools
        • 5.2.3.3. Structure Designing/ Building Tools
        • 5.2.3.4. Predictive Analytics
        • 5.2.3.5. Model Building Tools
        • 5.2.3.6. Others
      • 5.2.4. Global Drug Designing Tools Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Drug Designing Tools (Price)
      • 5.3.1. Global Drug Designing Tools by: Type (Price)
  • 6. Drug Designing Tools: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Schrödinger LLC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Biovia Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Albany Molecular Research Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BioSolveIT GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Agilent Technologies (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ChemAxon (Hungary)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novo Informatics Pvt. Ltd. (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Drug Designing Tools Sale, by Type, Application, Solution Type and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Drug Designing Tools (Value)
      • 7.2.1. Global Drug Designing Tools by: Type (Value)
        • 7.2.1.1. Ligand-based drug design
        • 7.2.1.2. Second, structure-based drug design.
      • 7.2.2. Global Drug Designing Tools by: Application (Value)
        • 7.2.2.1. Chemical Screening
        • 7.2.2.2. Molecular Modelling
        • 7.2.2.3. Target Prediction
        • 7.2.2.4. Binding Site Prediction
        • 7.2.2.5. Docking
      • 7.2.3. Global Drug Designing Tools by: Solution Type (Value)
        • 7.2.3.1. Multi Databases
        • 7.2.3.2. Virtual Screening Tools
        • 7.2.3.3. Structure Designing/ Building Tools
        • 7.2.3.4. Predictive Analytics
        • 7.2.3.5. Model Building Tools
        • 7.2.3.6. Others
      • 7.2.4. Global Drug Designing Tools Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Drug Designing Tools (Price)
      • 7.3.1. Global Drug Designing Tools by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Designing Tools: by Type(USD Million)
  • Table 2. Drug Designing Tools Ligand-based drug design , by Region USD Million (2017-2022)
  • Table 3. Drug Designing Tools Second, structure-based drug design. , by Region USD Million (2017-2022)
  • Table 4. Drug Designing Tools: by Application(USD Million)
  • Table 5. Drug Designing Tools Chemical Screening , by Region USD Million (2017-2022)
  • Table 6. Drug Designing Tools Molecular Modelling , by Region USD Million (2017-2022)
  • Table 7. Drug Designing Tools Target Prediction , by Region USD Million (2017-2022)
  • Table 8. Drug Designing Tools Binding Site Prediction , by Region USD Million (2017-2022)
  • Table 9. Drug Designing Tools Docking , by Region USD Million (2017-2022)
  • Table 10. Drug Designing Tools: by Solution Type(USD Million)
  • Table 11. Drug Designing Tools Multi Databases , by Region USD Million (2017-2022)
  • Table 12. Drug Designing Tools Virtual Screening Tools , by Region USD Million (2017-2022)
  • Table 13. Drug Designing Tools Structure Designing/ Building Tools , by Region USD Million (2017-2022)
  • Table 14. Drug Designing Tools Predictive Analytics , by Region USD Million (2017-2022)
  • Table 15. Drug Designing Tools Model Building Tools , by Region USD Million (2017-2022)
  • Table 16. Drug Designing Tools Others , by Region USD Million (2017-2022)
  • Table 17. South America Drug Designing Tools, by Country USD Million (2017-2022)
  • Table 18. South America Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 19. South America Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 20. South America Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 21. Brazil Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 22. Brazil Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 23. Brazil Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 24. Argentina Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 25. Argentina Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 26. Argentina Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 27. Rest of South America Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 28. Rest of South America Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 29. Rest of South America Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 30. Asia Pacific Drug Designing Tools, by Country USD Million (2017-2022)
  • Table 31. Asia Pacific Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 32. Asia Pacific Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 33. Asia Pacific Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 34. China Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 35. China Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 36. China Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 37. Japan Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 38. Japan Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 39. Japan Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 40. India Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 41. India Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 42. India Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 43. South Korea Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 44. South Korea Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 45. South Korea Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 46. Taiwan Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 47. Taiwan Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 48. Taiwan Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 49. Australia Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 50. Australia Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 51. Australia Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 55. Europe Drug Designing Tools, by Country USD Million (2017-2022)
  • Table 56. Europe Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 57. Europe Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 58. Europe Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 59. Germany Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 60. Germany Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 61. Germany Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 62. France Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 63. France Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 64. France Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 65. Italy Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 66. Italy Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 67. Italy Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 68. United Kingdom Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 69. United Kingdom Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 70. United Kingdom Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 71. Netherlands Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 72. Netherlands Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 73. Netherlands Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 74. Rest of Europe Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 75. Rest of Europe Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 76. Rest of Europe Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 77. MEA Drug Designing Tools, by Country USD Million (2017-2022)
  • Table 78. MEA Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 79. MEA Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 80. MEA Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 81. Middle East Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 82. Middle East Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 83. Middle East Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 84. Africa Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 85. Africa Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 86. Africa Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 87. North America Drug Designing Tools, by Country USD Million (2017-2022)
  • Table 88. North America Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 89. North America Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 90. North America Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 91. United States Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 92. United States Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 93. United States Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 94. Canada Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 95. Canada Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 96. Canada Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 97. Mexico Drug Designing Tools, by Type USD Million (2017-2022)
  • Table 98. Mexico Drug Designing Tools, by Application USD Million (2017-2022)
  • Table 99. Mexico Drug Designing Tools, by Solution Type USD Million (2017-2022)
  • Table 100. Drug Designing Tools: by Type(USD/Units)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Drug Designing Tools: by Type(USD Million)
  • Table 109. Drug Designing Tools Ligand-based drug design , by Region USD Million (2023-2028)
  • Table 110. Drug Designing Tools Second, structure-based drug design. , by Region USD Million (2023-2028)
  • Table 111. Drug Designing Tools: by Application(USD Million)
  • Table 112. Drug Designing Tools Chemical Screening , by Region USD Million (2023-2028)
  • Table 113. Drug Designing Tools Molecular Modelling , by Region USD Million (2023-2028)
  • Table 114. Drug Designing Tools Target Prediction , by Region USD Million (2023-2028)
  • Table 115. Drug Designing Tools Binding Site Prediction , by Region USD Million (2023-2028)
  • Table 116. Drug Designing Tools Docking , by Region USD Million (2023-2028)
  • Table 117. Drug Designing Tools: by Solution Type(USD Million)
  • Table 118. Drug Designing Tools Multi Databases , by Region USD Million (2023-2028)
  • Table 119. Drug Designing Tools Virtual Screening Tools , by Region USD Million (2023-2028)
  • Table 120. Drug Designing Tools Structure Designing/ Building Tools , by Region USD Million (2023-2028)
  • Table 121. Drug Designing Tools Predictive Analytics , by Region USD Million (2023-2028)
  • Table 122. Drug Designing Tools Model Building Tools , by Region USD Million (2023-2028)
  • Table 123. Drug Designing Tools Others , by Region USD Million (2023-2028)
  • Table 124. South America Drug Designing Tools, by Country USD Million (2023-2028)
  • Table 125. South America Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 126. South America Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 127. South America Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 128. Brazil Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 129. Brazil Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 130. Brazil Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 131. Argentina Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 132. Argentina Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 133. Argentina Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 134. Rest of South America Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 135. Rest of South America Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 136. Rest of South America Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 137. Asia Pacific Drug Designing Tools, by Country USD Million (2023-2028)
  • Table 138. Asia Pacific Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 139. Asia Pacific Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 140. Asia Pacific Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 141. China Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 142. China Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 143. China Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 144. Japan Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 145. Japan Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 146. Japan Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 147. India Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 148. India Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 149. India Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 150. South Korea Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 151. South Korea Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 152. South Korea Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 153. Taiwan Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 154. Taiwan Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 155. Taiwan Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 156. Australia Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 157. Australia Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 158. Australia Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 160. Rest of Asia-Pacific Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 161. Rest of Asia-Pacific Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 162. Europe Drug Designing Tools, by Country USD Million (2023-2028)
  • Table 163. Europe Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 164. Europe Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 165. Europe Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 166. Germany Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 167. Germany Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 168. Germany Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 169. France Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 170. France Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 171. France Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 172. Italy Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 173. Italy Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 174. Italy Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 175. United Kingdom Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 176. United Kingdom Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 177. United Kingdom Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 178. Netherlands Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 179. Netherlands Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 180. Netherlands Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 181. Rest of Europe Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 182. Rest of Europe Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 183. Rest of Europe Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 184. MEA Drug Designing Tools, by Country USD Million (2023-2028)
  • Table 185. MEA Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 186. MEA Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 187. MEA Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 188. Middle East Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 189. Middle East Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 190. Middle East Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 191. Africa Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 192. Africa Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 193. Africa Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 194. North America Drug Designing Tools, by Country USD Million (2023-2028)
  • Table 195. North America Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 196. North America Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 197. North America Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 198. United States Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 199. United States Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 200. United States Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 201. Canada Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 202. Canada Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 203. Canada Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 204. Mexico Drug Designing Tools, by Type USD Million (2023-2028)
  • Table 205. Mexico Drug Designing Tools, by Application USD Million (2023-2028)
  • Table 206. Mexico Drug Designing Tools, by Solution Type USD Million (2023-2028)
  • Table 207. Drug Designing Tools: by Type(USD/Units)
  • Table 208. Research Programs/Design for This Report
  • Table 209. Key Data Information from Secondary Sources
  • Table 210. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Designing Tools: by Type USD Million (2017-2022)
  • Figure 5. Global Drug Designing Tools: by Application USD Million (2017-2022)
  • Figure 6. Global Drug Designing Tools: by Solution Type USD Million (2017-2022)
  • Figure 7. South America Drug Designing Tools Share (%), by Country
  • Figure 8. Asia Pacific Drug Designing Tools Share (%), by Country
  • Figure 9. Europe Drug Designing Tools Share (%), by Country
  • Figure 10. MEA Drug Designing Tools Share (%), by Country
  • Figure 11. North America Drug Designing Tools Share (%), by Country
  • Figure 12. Global Drug Designing Tools: by Type USD/Units (2017-2022)
  • Figure 13. Global Drug Designing Tools share by Players 2022 (%)
  • Figure 14. Global Drug Designing Tools share by Players (Top 3) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Schrödinger LLC (United States) Revenue, Net Income and Gross profit
  • Figure 17. Schrödinger LLC (United States) Revenue: by Geography 2022
  • Figure 18. Biovia Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Biovia Corporation (United States) Revenue: by Geography 2022
  • Figure 20. Albany Molecular Research Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Albany Molecular Research Inc. (United States) Revenue: by Geography 2022
  • Figure 22. BioSolveIT GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 23. BioSolveIT GmbH (Germany) Revenue: by Geography 2022
  • Figure 24. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 25. Agilent Technologies (United States) Revenue: by Geography 2022
  • Figure 26. ChemAxon (Hungary) Revenue, Net Income and Gross profit
  • Figure 27. ChemAxon (Hungary) Revenue: by Geography 2022
  • Figure 28. Novo Informatics Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 29. Novo Informatics Pvt. Ltd. (India) Revenue: by Geography 2022
  • Figure 30. Global Drug Designing Tools: by Type USD Million (2023-2028)
  • Figure 31. Global Drug Designing Tools: by Application USD Million (2023-2028)
  • Figure 32. Global Drug Designing Tools: by Solution Type USD Million (2023-2028)
  • Figure 33. South America Drug Designing Tools Share (%), by Country
  • Figure 34. Asia Pacific Drug Designing Tools Share (%), by Country
  • Figure 35. Europe Drug Designing Tools Share (%), by Country
  • Figure 36. MEA Drug Designing Tools Share (%), by Country
  • Figure 37. North America Drug Designing Tools Share (%), by Country
  • Figure 38. Global Drug Designing Tools: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Schrödinger LLC (United States)
  • Biovia Corporation (United States)
  • Albany Molecular Research Inc. (United States)
  • BioSolveIT GmbH (Germany)
  • Agilent Technologies (United States)
  • ChemAxon (Hungary)
  • Novo Informatics Pvt. Ltd. (India)
Additional players considered in the study are as follows:
OpenEye Scientific Software Inc. (United States) , XtalPi Inc (United States) , Accelrys Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 236 Pages 67 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Designing Tools Market Quantitative research analysis
Global Drug Designing Tools Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Drug Designing Tools Market are Schrödinger LLC (United States), Biovia Corporation (United States), Albany Molecular Research Inc. (United States), BioSolveIT GmbH (Germany), Agilent Technologies (United States), ChemAxon (Hungary) and Novo Informatics Pvt. Ltd. (India) etc.
Chemical Screening segment in Global market to hold robust market share owing to "Growing Need for Cost- And Time-Effective Drug Designing Tools".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Drug Designing Tools market throughout the forecasted period.

Know More About Global Drug Designing Tools Market Report?

Have a Query? Click Here

Other Related Reports

Labeling Software Comprehensive Study by Application (FMCG, Retail, Healthcare, Warehousing and Logistics, Others), Deployment Model (Cloud-based, On-premise) Players and Region - Global Market Outlo...
$ 3500
Hospital Management Software Comprehensive Study by Application (Hospital, Clinics, Others), Module (Radiology Utilization Management Solutions, Event-Driven Solutions, Bed Management System, Online ...
$ 3650
Horizontal Portals Comprehensive Study by Type (Software, Services), Application (IT & Telecommunication, Healthcare, Military, Automotive, Consumer Electronics, Others), End Use (Customers, Clients,...
$ 3800
Real-time Production Monitoring Software Comprehensive Study by Application (Business Process Optimization, Logistics and Supply Chain Management, Automation and Control Management, Emergency and Inc...
$ 3750
Conversational AI Platform Comprehensive Study by Type (AI-powered Chatbots, Intelligent Virtual Assistant, Others (Messaging Apps)), Application (Lead Generation, Customer Engagement, Customer Suppo...
$ 3750
Electrical Design Software Comprehensive Study by Organization Size (Large Enterprise, Small Medium Enterprise), Deployment Type (Web-Based, Cloud-Based) Players and Region - Global Market Outlook to...
$ 3500